Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in PFE — Pfizer Inc

CIK 70858 CHARLOTTE, NC
Back to PFE Full portfolio

Position in PFE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,049,601,662
-$257,395,385 QoQ
Shares Held
43,588,109
-6.4% QoQ
Ownership
0.765%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#15
of 2,812 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 53% Shared 0% None 47%

Common Shares in PFE Over Time

Shares Held

Position Value (USD)

Derivatives in PFE

reported options exposure · as of Sep 30, 2025
CallValue
$102,044,852
CallShares
4,004,900
PutValue
$228,165,756
PutShares
8,954,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $41,356,581,132 across 16 Drug Manufacturers - General names. PFE ranks #9 (2.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 11,274,243 $13,522,666,405
2 JNJ
Johnson & Johnson
 23,438,141 $5,952,584,668
3 ABBV
AbbVie Inc.
 21,237,764 $5,344,270,929
4 MRK
Merck & Co., Inc.
 30,535,208 $3,923,774,226
5 AZN
Astrazeneca PLC
 17,690,462 $3,354,465,400
6 GILD
Gilead Sciences, Inc.
 18,649,065 $2,356,122,869
7 BMY
Bristol Myers Squibb Co
 34,045,352 $1,961,693,176
8 AMGN
Amgen Inc
 5,058,830 $1,831,903,515

All Filings in PFE

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,049,601,662 43,588,109
2026-03-31 $1,306,997,047 46,545,479
2025-12-31 $1,214,651,677 48,781,192
2025-09-30 $228,165,756 8,954,700
2025-09-30 $1,131,684,997 44,414,639
2025-09-30 $102,044,852 4,004,900
2025-06-30 $1,247,398,371 51,460,329
2025-06-30 $77,012,904 3,177,100
2025-06-30 $208,897,896 8,617,900
2025-03-31 $168,138,502 6,635,300
2025-03-31 $1,420,698,855 56,065,464
2025-03-31 $297,965,458 11,758,700
2024-12-31 $1,196,637,557 45,105,072
2024-12-31 $146,352,745 5,516,500
2024-12-31 $79,733,262 3,005,400
2024-09-30 $160,938,234 5,561,100
2024-09-30 $1,573,251,818 54,362,537
2024-09-30 $88,307,516 3,051,400
2024-06-30 $37,991,244 1,357,800
2024-06-30 $1,465,787,641 52,386,978
2024-06-30 $112,051,506 4,004,700
2024-03-31 $54,473,250 1,963,000
2024-03-31 $1,457,090,421 52,507,763
2024-03-31 $90,132,000 3,248,000
2023-12-31 $63,885,010 2,219,000
2023-12-31 $1,378,641,132 47,886,111
2023-12-31 $122,697,222 4,261,800
2023-09-30 $70,900,875 2,137,500
2023-09-30 $88,951,989 2,681,700
2023-09-30 $1,731,306,222 52,194,942
2023-06-30 $2,186,827,192 59,619,062
2023-06-30 $80,384,220 2,191,500
2023-06-30 $42,237,020 1,151,500
2023-03-31 $80,469,840 1,972,300
2023-03-31 $2,643,888,916 64,801,199
2023-03-31 $104,415,360 2,559,200
2022-12-31 $90,986,868 1,775,700
2022-12-31 $188,281,380 3,674,500
2022-12-31 $3,200,444,813 62,459,891
2022-09-30 $2,680,745,341 61,260,177
2022-09-30 $172,628,824 3,944,900
2022-09-30 $94,981,080 2,170,500
2022-06-30 $3,238,979,117 61,777,210
2022-06-30 $122,874,948 2,343,600
2022-06-30 $99,470,196 1,897,200
2022-03-31 $112,713,644 2,177,200
2022-03-31 $3,054,329,925 58,998,067
2022-03-31 $22,752,915 439,500
2021-12-31 $125,859,170 2,131,400
2021-12-31 $379,372,630 6,424,600

Report a Problem

Category
Description
Email (optional, for follow-up)